Kevin E. Shaw is an accomplished Executive Sales and Commercialization Leader whose career spans more than 25 years of driving transformative growth across the medical device and healthcare technology sectors. Throughout his professional journey, Kevin has demonstrated a rare ability to integrate strategic vision with operational execution, enabling organizations to move from early innovation to market dominance. His career reflects an unwavering commitment to elevating new technologies into standards of care, shaping industry landscapes, and empowering teams to achieve breakthrough success.

From the earliest stages of his career, Kevin displayed a natural talent for understanding complex clinical value propositions and translating them into compelling commercial strategies. His foundational years in dental and surgical product sales provided more than technical exposure—they cultivated a deep respect for surgeon engagement, frontline education, and the power of clear messaging. These early experiences set the tone for a trajectory defined by leadership in highly regulated, rapidly evolving medical markets.

Kevin’s rise accelerated sharply during his tenure with Medtronic Spinal & Biologics, where he led Western U.S. sales operations during one of the most explosive growth phases in spine device history. He orchestrated a regional turnaround that produced $13 million in revenue within 11 months and contributed to the broader organization’s leap from $0 to $43 million in the same period. His leadership also played a pivotal role in the successful integration of St. Francis Medical Technologies into Kyphon and later into Medtronic following multi-billion-dollar acquisitions. This period showcased Kevin’s ability to lead organizations through intense change while preserving momentum, talent, and culture.

His impact deepened further at SI-Bone, where he built an entire commercial infrastructure from the ground up. Kevin established and led a 45-person sales and management team, built training systems for more than 700 surgeons, and grew revenue from zero to more than $45 million in just three years. His commercialization model became a blueprint for scaling disruptive implant technologies, and his contributions were instrumental to SI-Bone’s IPO. Few executives in the industry have overseen this level of organizational expansion with such precision and speed.

Kevin continued this momentum at Providence Medical Technology, where he again proved his ability to scale a company from early-stage promise to broader adoption. He developed hybrid sales models, created surgeon-focused education programs, managed an extensive P&L, and built a distributor network that rapidly grew market penetration. His strategies enabled new technologies to overcome initial skepticism and achieve widespread clinical endorsement—evidence of his intuitive grasp of both market readiness and surgeon psychology.

His leadership reached even greater breadth with OsteoCentric Technologies, where he guided commercialization efforts across multiple verticals including Trauma, Spine, Dental, and Sports Medicine. Kevin not only built and trained high-performance sales teams but also secured internal investment approval for major strategic initiatives, including a $50 million expense budget aligned with long-term revenue targets. His work with key opinion leaders further cemented clinical credibility for emergent technologies, accelerating adoption in highly competitive markets.

Today, as Chief Commercialization Officer and leader of Shaw-Blue Sky Consulting, Kevin channels his expertise into guiding startups, founders, and boards through the complexities of market entry, sales architecture, and brand positioning. He is widely recognized for spearheading turnaround strategies that simultaneously reduce operating expenses and expand case volume, demonstrating his balance of analytical rigor and creative problem-solving. His consulting practice reflects his passion for elevating innovative ideas into commercially viable, scalable solutions that genuinely improve patient care.

Known for his strategic clarity and ability to simplify complexity, Kevin excels in shaping messaging frameworks that resonate with surgeons, investors, and internal teams alike. His board-level reporting and cross-functional leadership have influenced product development, market strategy, and long-term organizational design for companies across the medical technology landscape. Whether guiding a startup through its first commercialization steps or repositioning an established company for accelerated growth, he brings a steady, insightful perspective rooted in decades of hands-on experience.

Beyond his professional achievements, Kevin is guided by a strong sense of purpose grounded in leadership, integrity, and the belief that meaningful innovation must serve both clinicians and patients. His personal values reflect a commitment to continuous improvement, collaboration, and strategic foresight. Outside of work, he finds balance through travel, family, skiing, and music—pursuits that reflect his appreciation for connection, culture, and creativity.

Character:
Kevin exemplifies character through his principled leadership, commitment to ethical decision-making, and respect for the teams he serves. He consistently brings humility to his work, valuing collaboration over ego and long-term impact over short-term gains. His integrity builds trust with surgeons, executives, and colleagues, enabling him to guide organizations through both growth and adversity with confidence.

Knowledge:
His extensive experience in commercialization, sales strategy, and medical device markets reflects deep industry knowledge cultivated across decades. He continuously seeks to understand emerging technologies, evolving clinical landscapes, and shifts in market dynamics. Kevin’s ability to synthesize complex information into clear strategic direction is one of his defining professional strengths.

Strategic:
Kevin approaches every challenge with a forward-thinking mindset, aligning tactical execution with long-range organizational goals. He has a proven ability to map pathways from early innovation to scalable market success, even in competitive or constrained environments. His strategic influence shapes not only sales performance but entire organizational trajectories.

Communication:
A communication style that is clear, compelling, and grounded in authenticity, enabling him to inspire teams and build consensus across diverse stakeholders. He excels at translating clinical value into persuasive commercial messaging that resonates with surgeons and investors. His ability to articulate vision and direction strengthens organizational focus and fuels team alignment.